Dr. Boon is a senior epidemiologist with expertise in pesticides, infectious diseases, and molecular biology.  Before joining Gradient, Dr. Boon was a senior epidemiologist at an agriscience company, where she led the company’s environmental epidemiology strategy and efforts, and was also responsible for global human health risk assessments of a portfolio of chemicals.  Dr. Boon focused her doctoral and postdoctoral research on the development and implementation of novel methods to estimate the incidence of hepatitis C virus (HCV) and HIV infections.  She also contributed to research on the molecular epidemiology of SARS-CoV-2 and COVID-19, and served as co-lead of the Johns Hopkins University Novel Coronavirus Research Compendium’s Diagnostics Team.  Prior to pursuing her graduate studies, Dr. Boon worked at the National Institutes of Health (NIH) on science communication and grants administration in the extramural research program, and conducted research on the host immune response to and pathogenesis of human viral infections in the intramural research program.